Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jul 23:12:2050313X241265072.
doi: 10.1177/2050313X241265072. eCollection 2024.

Glycemic impact of gabapentin and Nucleo C.M.P in metformin-controlled diabetic patients: A case report

Hashim Talib Hashim  1 , Ahmed Qasim Mohammed Alhatemi  2 , Narjiss Aji  3 , Jaffer Shah  4
Affiliations
Case Reports

Glycemic impact of gabapentin and Nucleo C.M.P in metformin-controlled diabetic patients: A case report

Hashim Talib Hashim et al. SAGE Open Med Case Rep. .

Abstract

This study examines the contraindications of gabapentin and Nucleo C.M.P Forte in metformin-controlled diabetic patients, focusing on their potential to induce hyperglycemia. A case report of a 65-year-old woman with type II diabetes is presented, demonstrating elevated blood glucose levels following the initiation of gabapentin and Nucleo C.M.P Forte. The literature review highlights limited data on gabapentin-induced hyperglycemia, with additional consideration of the potential effects of Nucleo C.M.P Forte. The study suggests modifying insulin therapy in diabetic patients taking gabapentin and calls for further research on this interaction.

Keywords: Metformin; diabetes mellitus; diabetic neuropathy; gabapentin; intervertebral disk displacement.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Goa K, Sorkin E. Gabapentin. Drugs 1993; 46: 409–427. - PubMed
    1. McLean M, Gidal B. Gabapentin dosing in the treatment of epilepsy. Clin Ther 2003; 25: 1382–1406. - PubMed
    1. Martynyuk L, Makarchuk N, Shved M, et al. The clinical efficacy of nucleo CMP forte usage in the combined treatment of diabetic peripheral neuropathy. Endocr Abstr 2017; 49: P674.
    1. Alfaris AA, Radha ZH, Hamza BS. Efficacy of nucleo CMP forte in traumatic brain injury in pediatrics: a randomized controlled trial. Pain Manag 2023; 9: 123–129.
    1. Povedano M, Martinez Y, Tejado A, et al. Observational pilot study of patients with carpal tunnel syndrome treated with Nucleo CMP Forte™. Pain Manag 2019; 9: 123–129. - PubMed

Publication types

LinkOut - more resources